Document:

Nite Capital, LP Warrant C

    THE
      SECURITIES REPRESENTED BY THIS WARRANT CERTIFICATE AND THE SHARES OF COMMON
      STOCK ISSUABLE UPON EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE
      SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”),
      OR APPLICABLE STATE SECURITIES LAWS AND NO INTEREST THEREIN MAY BE SOLD,
      TRANSFERRED OR OTHERWISE DISPOSED OF UNLESS (1) A REGISTRATION STATEMENT WITH
      RESPECT TO SUCH SECURITIES SHALL BE EFFECTIVE UNDER THE ACT AND ANY APPLICABLE
      STATE SECURITIES LAWS OR (2) SUCH SECURITIES ARE TRANSFERRED PURSUANT TO RULE
      144 PROMULGATED UNDER THE ACT (OR ANY SUCCESSOR RULE) OR (3) COMPREHENSIVE
      HEALTHCARE SOLUTIONS, INC. SHALL HAVE RECEIVED AN OPINION OF COUNSEL REASONABLY
      SATISFACTORY TO IT THAT NO VIOLATION OF THE ACT WILL BE INVOLVED IN SUCH
      TRANSFER.

     

    COMPREHENSIVE
      HEALTHCARE SOLUTIONS, INC.

     

    EXERCISABLE
      AT OR BEFORE

     

    5:00
      P.M., EASTERN TIME, AUGUST 3, 2010

     

    No.
      1                                                                                                                                                                       Warrant
      to Purchase

                                                                                                                                                                                    500,000
      Shares

     

    WARRANT
      TO PURCHASE SHARES

     

    OF
      COMMON STOCK

     

    THIS
      CERTIFIES THAT,
      for
      value received, COMPREHENSIVE
      ASSOCIATES LLC,
      a New
      York limited liability company (together with its successors and assigns, the
      “Holder”),
      with
      offices at 64 Shelter Lane, Roslyn, New York 11577, is entitled to subscribe
      for
      and purchase up to FIVE
      HUNDRED THOUSAND (500,000)
      shares,
      as adjusted pursuant to Section 4 (the “Shares”),
      of
      the fully paid and nonassessable common stock, par value $.10 per share (the
      “Common
      Stock”)
      of
COMPREHENSIVE
      HEALTHCARE SOLUTIONS, INC.,
      a
      Delaware corporation (the “Company”),
      at
      the price of THIRTY-FIVE CENTS ($0.35)
      per
      share (such price, and such other prices that shall result from time to time,
      from the adjustments specified in Section 4, the “Warrant
      Price”),
      subject to the provisions and upon the terms and conditions hereinafter set
      forth.

     

    1.  Term.
      The
      purchase right represented by this Warrant is exercisable, in whole or in part,
      at any time, and from time to time, from and after the date hereof and until
      5:00 p.m., Eastern Time, August 3, 2010. 

     

    2.  Method
      of Exercise; Payment; Issuance of New Warrant.
      

     

    (a)  The
      purchase right represented by this Warrant may be exercised by the Holder,
      in
      whole or in part and from time to time, by the surrender of this Warrant (with
      the notice of exercise form attached hereto as Annex I
      duly
      executed) at the principal office of the Company and by the payment to the
      Company of the Warrant Price in cash. 

     

     

    
      
         

      

      
         

        
          

        

      

      
         

      

    

     

    (b)  The
      persons or entities in whose name(s) any certificate(s) representing Shares
      shall be issuable upon exercise of this Warrant shall be deemed to have become
      the holder(s) of record of, and shall be treated for all purposes as the record
      holder(s) of, the Shares represented thereby (and such Shares shall be deemed
      to
      have been issued) immediately prior to the close of business on the date or
      dates upon which this Warrant is properly exercised and full payment for the
      Shares acquired pursuant to such exercise is made. Upon any exercise of the
      rights represented by this Warrant, certificates for the Shares purchased shall
      be delivered to the Holder hereof within one (1) day of receipt of such notice
      and payment, and unless this Warrant has been fully exercised or expired, a
      new
      Warrant representing the portion of Shares, if any, with respect to which this
      Warrant shall not then have been exercised shall also be issued to the holder
      hereof as soon as possible but in any event within five (5) days.

     

    3.  Stock
      Fully Paid, Reservation of Shares.
      All
      Shares that may be issued upon the exercise of this Warrant will, upon issuance,
      be duly and validly authorized and issued, fully paid and nonassessable, and
      will be free from all transfer taxes, liens and charges with respect to the
      issue thereof and assuming payment of the applicable consideration for all
      Shares so purchased, legally and validly owned by the Holder. During the period
      within which this Warrant may be exercised, the Company will at all times have
      authorized, and reserved for the sole purpose of the issue upon the exercise
      of
      the purchase rights evidenced by this Warrant, a sufficient number of shares
      of
      its Common Stock to provide for the exercise of the rights represented by this
      Warrant; and if at any time the number of authorized shares of Common Stock
      shall not be sufficient to effect the exercise of this Warrant, the Company
      will
      take such corporate action as may be necessary to increase its authorized shares
      of Common Stock to such number of shares as shall be sufficient for such
      purpose; the Company shall have analogous obligations with respect to any other
      securities or property issuable upon exercise of this Warrant. As long as this
      Warrant shall be outstanding, the Company shall use its best efforts to cause
      all shares of Common Stock issuable upon exercise of this Warrant to be listed
      and/or quoted on all securities exchanges and/or Nasdaq or other medium on
      which
      such shares may then be listed.

     

    4.  Adjustment
      of Warrant Price and Number of Shares.
      The
      number and kind of securities purchasable upon the exercise of this Warrant
      and
      the Warrant Price shall be subject to the adjustment from time to time upon
      the
      occurrence of certain events, as follows:

     

    (a)  No
      Impairment.
      The
      Company shall not, by amendment of its Certificate of Incorporation or By-laws
      or through any reorganization, recapitalization, transfer of assets,
      consolidation, merger, dissolution, issue or sale of securities or any other
      voluntary action, avoid or seek to avoid the observance or performance of any
      of
      the terms to be observed or performed hereunder by the Company, but will at
      all
      times in good faith assist in the carrying out of all the provisions of this
      Section 4 and in the taking of all such action as may be necessary or
      appropriate in order to protect the rights of the Holder against
      impairment.

     

     

    
      
         

      

      
         

        
          

        

      

      
         

      

    

     

    (b)  Below
      Exercise Price Issuance; Stock Dividends; Etc.
      

     

    	(i)  	
            Sale
              of Shares Below Warrant
              Price.

          

     

    (A)  If
      at any
      time or from time to time after the date hereof the Company issues or sells
      shares of Common Stock or Common Stock Equivalents (as hereinafter defined)
      (other than as a dividend or other distribution on any class of stock as
      provided in Section 4(b)(ii)
      below,
      or
      a subdivision or combination of shares as provided in Section 4(b)(iii)
      below)
      for an Effective
      Price (as hereinafter defined) that is less than the
      Warrant
      Price then in effect,
      then,
      and in each such case, the then existing Warrant
      Price shall be reduced, as of the opening of business on the date of
such
      issue or sale,
      to
the
      Effective Price. For purposes hereof,

     

    (I)  a
      “Common
      Stock Equivalent”
shall
      mean each share of Common Stock into which securities or property or rights
      are
      convertible, exchangeable or exercisable for or into shares of Common Stock,
      or
      otherwise entitle the holder thereof to receive directly or indirectly, any
      of
      the foregoing (provided
      that the
      Warrant Price shall be adjusted to reflect any termination of such instruments
      prior to the exercise of this Warrant); and 

     

    (II)  the
      “Effective
      Price”
of
      

     

    (x)
       a
      Common
      Stock Equivalent shall mean the sum of (x) the fair market value of the
      consideration paid for such security plus (y) the fair market value of the
      minimum consideration, if any, to be paid for the conversion, exercise or
      exchange of such security for or into each share of Common Stock, in each case
      on a per share of Common Stock basis (provided
      that the
      Warrant Price shall be adjusted to reflect adjustments to the Effective Price
      based upon any change in such minimum consideration to be paid prior to the
      exercise of this Warrant) and 

     

    (y)
       a
      share
      of Common Stock issued by the Company (other than upon the conversion, exercise
      or exchange of Common Stock Equivalents) shall be the fair market value of
      the
      consideration paid for such share of Common Stock.

     

    (B)  Consideration
      Received for Securities.
      For the
      purpose of making any adjustment required under this Section 4(b)(i),
      the
      consideration received by the Company for any issue or sale of securities shall
      (x) to
      the
      extent it consists of cash, be computed at the gross amount of cash received
      by
      the Company prior to deduction of any underwriting or similar commissions,
      compensation or concessions paid or allowed by the Company in connection with
      such
      issue or sale and
      without deduction of any expenses payable by the Company, and
      (y) to
      the
      extent it consists of property other than cash, be computed at the fair market
      value of that property as determined, in good faith, by the Board of Directors,
      and if
      additional
      shares of Common Stock and/or Common Stock Equivalents
      are
      issued or sold together with other stock or securities or other assets of the
      Company for a consideration which covers both, be computed as the portion of
      the
      consideration so received that may be reasonably determined, in good faith,
      by
      the Board of Directors to be allocable to such additional shares of Common
      Stock
and/or
      Common Stock Equivalents, which determination shall be subject to the approval
      of the
      Holder; provided
      that, in
      the event the Holder does not agree with the Company's determination of the
      value of such consideration, the 

     

     

    
      
         

      

      
         

        
          

        

      

      
         

      

       

       

      parties
        shall mutually agree upon and appoint an appraiser which shall be commissioned
        to investigate the value of the property to be distributed and shall submit
        a
        notice of an appraisal of that value to the Company and to the
        Holder within thirty (30) days of such commission. The appraiser shall be
        instructed to determine such value without regard to income tax consequences
        to
        the recipient as a result of receiving consideration other than cash. The
        value
        determined by the appraiser shall be conclusive. 

    

     

    (ii)  Adjustment
      for Common Stock Dividends and Distributions.
      If, at
      any time after the date hereof, the Company makes, or fixes a record date for
      the determination of holders of Common Stock entitled to receive, a dividend
      or
      other distribution payable in additional shares of Common Stock or Common Stock
      Equivalents, in each such event the Warrant
      Price that is then in effect shall be decreased as of the time of such issuance
      or, in the event such record date is fixed, as of the
      close
      of business on such record date,
      by
      multiplying the Warrant
      Price then in effect by a fraction (A) the
      numerator of which is the total number of shares of Common Stock and Common
      Stock Equivalents issued and outstanding immediately prior to the time of such
      issuance or the
      close
      of business on such record date,
      and
(B) the
      denominator of which is the total number of shares of Common Stock and Common
      Stock Equivalents issued and outstanding immediately prior to the time of such
      issuance or the
      close
      of business on such record date plus
      the
      number of shares of Common Stock or Common Stock Equivalents issuable in payment
      of such dividend or distribution; provided,
      however,
      that if
      such record date is fixed and such dividend is not fully paid or if such
      distribution is not fully made on the date fixed therefor, the Warrant
      Price shall be recomputed accordingly as of the
      close
      of business on such record date and
      thereafter the Warrant
      Price shall be adjusted pursuant to this Section 4(b)(ii) to reflect the
      actual payment of such dividend or distribution.

     

    (iii)  Adjustments
      for Stock Splits, Stock Subdivisions and Combinations.
      If, at
      any time after the date hereof, the Company subdivides or combines the Common
      Stock, (A) in
      the
      case of a subdivision (including a stock split), the Warrant
      Price in effect immediately
      prior to such event
      shall be proportionately decreased and the number of shares of Common Stock
      purchasable hereunder shall be proportionately increased, and (B) in
      the
      case of a combination (including a reverse stock split), the Warrant
      Price in effect immediately
      prior to such event
      shall be proportionately increased and the number of shares of Common Stock
      purchasable hereunder shall be proportionately decreased. Any adjustment under
      this Section 4(b)(iii)
      shall
      become effective at the
      close
      of business on the date the
      subdivision or combination becomes effective.

     

    (iv)  Adjustments
      for Reclassification, Reorganization, Merger, Consolidation and
      Sale.
      In case
      of (A) any
      reclassification, reorganization, change or conversion of securities of the
      Common Stock (other than a change in par value, or from par value to no par
      value) into other shares or securities of the Company, or (B) any
      merger or consolidation of the Company with or into another entity (other than
      a
      merger or consolidation with another entity in which the Company is the
      acquiring and the surviving entity and that does not result in any
      reclassification or change of the Common Stock),
      or
(C) any
      sale
      of all or substantially all the assets of the Company, the 

     

     

    
      
         

      

      
         

        
          

        

      

      
         

      

       

       

       

      Holder
        shall
        have the right to receive, in lieu of the shares of Common Stock for
        which
        this Warrant is exercisable, the kind and amount of shares of stock and other
        securities, money and property receivable upon such reclassification,
        reorganization, change, merger or consolidation upon exercise by the Holder
        of
        the maximum number of shares of Common Stock for which this Warrant could
        have been exercised immediately
        prior to such reclassification,
        reorganization, change, merger, consolidation or sale, all subject to further
        adjustment as provided herein or with respect to such other securities or
        property by the terms thereof. The provisions of this clause (iv)
        shall
        similarly attach to successive reclassifications, reorganizations, changes,
        mergers, consolidations or sales.

    

     

    (c)  Other
      Distributions.
      In the
      event the Company provides the holders of its Common Stock with consideration
      that is not otherwise addressed in this Section 4 (including, without
      limitation, declaring a distribution payable in securities, assets, cash or
      evidences of indebtedness issued by other persons or the Company (excluding
      cash
      dividends declared and paid by the Company out of retained earnings), then,
      in
      each such case, the Holder shall be entitled to a pro rata
      share of
      any such distribution as though the Holder was a holder of the number of shares
      of Common Stock of the Company issuable upon the exercise of this Warrant in
      whole as of the record date fixed for the determination of the holders of Common
      Stock of the Company entitled to receive such distribution.

     

    (d)  Recapitalizations.
      If at
      any time there occurs a recapitalization of the Common Stock (other than a
      subdivision, combination, merger, consolidation or sale of assets provided
      for
      in this Section 4), the Holder shall be entitled to receive upon exercise
      of this Warrant the number of shares of capital stock or other securities or
      property of the Company or otherwise, to which a holder of the Common Stock
      deliverable upon exercise would have been entitled on such recapitalization.
      In
      any such case, appropriate adjustment shall be made in the application of the
      provisions of this Section 4 with respect to the rights of the Holder after
      the
      recapitalization to the end that the provisions of this Section 4 (including
      adjustment of the Warrant Price then in effect and the number of shares
      purchasable upon exercise of this Warrant) shall be applicable after that event
      as nearly equivalent as may be practicable.

     

    (e)  Notice
      of Adjustments.
      Whenever there shall be any change pursuant to this Section 4, the Company
      shall
      prepare a certificate setting forth, in reasonable detail, the event requiring
      the change and the kind and amount of shares of stock and other securities,
      money and property subsequently issuable upon an exercise hereof. Such
      certificate shall be signed by its chief financial officer and shall be
      delivered to the Holder or such other person as the Holder or any successor
      notice recipient may designate.

     

    (f)  Fractional
      Shares; Rounding.
      No
      fractional shares of Common Stock will be issued in connection with any exercise
      hereunder, but in lieu of such fractional shares, the number of shares of Common
      Stock to be received by the Holder upon exercise shall be
      rounded up to the nearest whole share.
      All
      calculations under this Section 4 shall be made to the nearest cent or to
      the nearest one-hundredth of a share, as the case may be.

     

     

    
      
         

      

      
         

        
          

        

      

      
         

      

    

     

    5.  Compliance
      with Securities Act; Disposition of Warrant or Shares of Common
      Stock.
      

     

    (a) The
      Holder, by acceptance hereof, agrees that this Warrant and the Shares to be
      issued upon the exercise hereof are being acquired for investment and that
      such
      holder will not offer, sell or otherwise dispose of this Warrant or any Shares
      to be issued upon the exercise hereof except under circumstances which will
      not
      result in a violation of applicable securities laws. All Shares issued upon
      exercise of this Warrant (unless registered under the Act) shall be stamped
      or
      imprinted with a legend in substantially the following form:

     

    “THE
      SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE
      SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”),
      OR APPLICABLE STATE SECURITIES LAWS AND NO INTEREST THEREIN MAY BE SOLD,
      TRANSFERRED OR OTHERWISE DISPOSED OF UNLESS (1) A REGISTRATION STATEMENT WITH
      RESPECT TO SUCH SECURITIES SHALL BE EFFECTIVE UNDER THE ACT AND ANY APPLICABLE
      STATE SECURITIES LAWS OR (2) SUCH SECURITIES ARE TRANSFERRED PURSUANT TO RULE
      144 PROMULGATED UNDER THE ACT (OR ANY SUCCESSOR RULE) OR (3) COMPREHENSIVE
      HEALTHCARE SOLUTIONS, INC. SHALL HAVE RECEIVED AN OPINION OF COUNSEL REASONABLY
      SATISFACTORY TO IT THAT NO VIOLATION OF THE ACT WILL BE INVOLVED IN SUCH
      TRANSFER.”

     

    (b)  Subject
      to the Company’s prior approval, which will not be unreasonably withheld,
      delayed or conditioned, this Warrant may be transferred or assigned, in whole
      or
      in part, by the Holder. Notwithstanding the foregoing, this Warrant may be
      transferred or assigned, in whole or in part, by the Holder to its members
      without the prior approval of the Company. This Warrant and all of the
      provisions hereof shall be binding upon and inure to the benefit of the Company,
      the Holder and their respective successors and assigns.

     

    (c)  Pursuant
      to a Registration Rights Agreement of even date between the Company and the
      Holder, the Holder has been granted certain registration rights with respect
      to
      the resale of the Shares issuable upon the exercise thereof.

     

    6.  Rights
      as a Shareholder.
      The
      Holder, as such, shall not be entitled to vote or receive dividends or be deemed
      the holder of Shares or any other securities of the Company which may at any
      time be issuable on the exercise hereof, nor shall anything contained herein
      be
      construed to confer upon the Holder, as such, any right to vote as a shareholder
      for the election of directors or upon any matter submitted to shareholders
      at
      any meeting thereof, or to receive notice of meetings, or to receive dividends
      or subscription rights or otherwise until this Warrant is exercised and the
      Shares purchasable upon the exercise hereof shall have become deliverable,
      as
      provided herein.

     

     

    
      
         

      

      
         

        
          

        

      

      
         

      

    

     

    7.  Representations
      and Warranties.
      The
      Company represents and warrants to the Holder as follows:

     

    (a) The
      Company has all requisite corporate power and authority to authorize and execute
      this Warrant and the certificates evidencing the Shares and to perform all
      obligations and undertakings under this Warrant; 

     

    (b)
       This
      Warrant has been duly authorized and executed by the Company and is a valid
      and
      binding obligation of the Company enforceable in accordance with its
      terms;

     

    (c) The
      Shares have been duly authorized and reserved for issuance by the Company and,
      when issued in accordance with the terms hereof, will be validly issued, fully
      paid and nonassessable; and

     

    (d)  Neither
      the execution and delivery of this Warrant, nor the issuance of the Shares
      upon
      exercise of this Warrant in accordance with the terms hereof, will be
      inconsistent with the Company’s Certificate of Incorporation or By-laws, as
      amended, and do not and will not constitute a default under any indenture,
      mortgage, contract, other instrument, judgment, decree or order to which the
      Company is a party or by which it is bound.

     

    8.  Miscellaneous.
      (a)  This Warrant represents the entire agreement between the parties
      hereto with respect to the subject matter thereof. This Warrant may not be
      modified or amended, or any provisions hereof waived, except by written
      agreement of the Company and the Holder.

     

    (b)  All
      notices, demands and requests of any kind to be delivered to any party in
      connection with this Warrant shall be in writing and shall be deemed to have
      been duly given if personally or hand delivered or if sent by a recognized
      overnight delivery courier or by registered or certified mail, return receipt
      requested and postage prepaid, or by facsimile transmission addressed as
      follows:

     

           (i)  if
      to the
      Company, to:

     

    Comprehensive
      Healthcare Solutions, Inc.

    45
      Ludlow
      Street, Suite 602

    Yonkers,
      New York 10705

    Attention:
      John H. Treglia, Chairman of the Board & Chief Executive
      Officer

    Facsimile:
      (914) 375-3696

     

     

    
 

    
      
         

      

      
         

        
          

        

      

      
         

      

    

     

     

    with
      a
      copy to:

    

    Anslow
      & Jaclin, LLP

    195
      Route
      9, Suite 204

    Manalapan,
      New Jersey 07726

    Attention:
      Gregg E. Jaclin, Esq.

    Facsimile:
      (732) 577-1188

     

    (ii)  if
      to the
      Holder, to:

     

    Comprehensive
      Associates LLC

    64
      Shelter Lane

    Roslyn,
      New York 11577

    Attention:
      Robyn Schreiber

    Facsimile:
      (516) 621-9172

    

    with
      a
      copy to:

    

    Certilman
      Balin Adler & Hyman, LLP

    90
      Merrick Avenue, 9th Floor

    East
      Meadow, New York 11554

    Attention:
      Fred Skolnik, Esq.

    Facsimile:
      (516) 296-7111

    

    or
      to
      such other address as the party to whom notice is to be given may have furnished
      to the other party hereto in writing in accordance with provisions of this
      Section 7. Any such notice or communication shall be deemed to have been
      effectively given (i) in the case of personal or hand delivery, on the date
      of such delivery, (ii) in the case of a recognized overnight delivery
      courier, on the business day after the date when sent, (iii) in the case of
      mailing, on the third business day following that day on which the piece of
      mail
      containing such communication is posted and (iv) in the case of facsimile
      transmission, on the date of transmission. 

     

    (c)  The
      Company covenants to the Holder that upon receipt of a description of
      circumstances reasonably satisfactory to the Company of the loss, theft,
      destruction or mutilation of this Warrant and, in the case of any such loss,
      theft or destruction, upon receipt of an indemnity reasonably satisfactory
      to
      the Company, or in the case of any such mutilation upon surrender and
      cancellation of such Warrant, the Company will make and deliver a new Warrant,
      of like tenor, in lieu of the lost, stolen, destroyed or mutilated
      Warrant.

    

    (d)  The
      descriptive headings of the several sections and paragraphs contained in this
      Warrant are for reference purposes only and shall not affect in anyway the
      meaning or interpretation of this Warrant.

     

     

    
      
         

      

      
         

        
          

        

      

      
         

      

    

    
 

    (e)  This
      Warrant shall be governed by and construed in accordance with the internal
      laws
      of the State of New York, without giving effect to the principles of conflicts
      of laws. 

    

    (f)  The
      invalidity of any of the provisions of this Warrant shall not invalidate or
      otherwise affect any of the other provisions of this Warrant, which shall remain
      in full force and effect.

    

    (g)  The
      Company acknowledges that it has been represented by counsel in connection
      with
      this Warrant. Accordingly, any rule or law or any legal decision that would
      require the interpretation of any claimed ambiguities in this Warrant against
      the party that drafted it has no application and is expressly waived by the
      Company. The provisions of this Warrant shall be interpreted in a reasonable
      manner to give effect to the intent of the parties hereto.

    

    

    {Remainder
      of page intentionally left blank. Signature page
      follows.}

    

     

    
      
        
          

        

         

      

      
         

        
          

        

      

      
         

        
          

        

      

    

    IN
      WITNESS WHEREOF,
      the
      Company has caused this Warrant to be duly executed by a duly authorized officer
      as of the 3rd
      day of
      August, 2005.

     

    COMPREHENSIVE
      HEALTHCARE SOLUTIONS, INC.

    

    

    By:
      ______________________________

    John
      Treglia,

    Chairman
      of the Board & Chief Executive Officer

     

    
      
        
          

        

         

      

      
         

        
          

        

      

      
         

        
          

        

      

    

    

     

    FORM
      OF EXERCISE NOTICE

     

    To:     Comprehensive
      Healthcare Solutions, Inc.

            45
      Ludlow
      Street, Suite 602

    Yonkers,
      New York 10705

    Attention:
      John Treglia

    Facsimile:
      (914) 375-3696

    

     

    1.  The
      undersigned hereby elects to purchase __________ shares of Common Stock of
      Comprehensive Healthcare Solutions, Inc. pursuant to the terms of the attached
      Warrant, and tenders herewith full payment of the purchase price of such shares
      in cash. 

     

    2.  Please
      issue a certificate or certificates representing said shares in the name of
      the
      undersigned or in such other name or names as are specified below:

     

    (Name)

     

    (Address)

     

    3.  The
      undersigned represents that the aforesaid shares are being acquired for the
      account of the undersigned for investment and not with a view to, or for resale
      in connection with, the distribution thereof and that the undersigned has no
      present intention of distributing or reselling such shares in a manner that
      would cause the issuance of the underlying shares to be in violation of
      applicable securities laws.

     

     

     

    

     

    By:      

     

    

     

    Address:     

     

     

     

    

     

    Taxpayer
      Identification No.:   

     

    

     

    Date:  _________________________Nite Capital, LP Subscription agreement

    THE
      SECURITIES REPRESENTED BY THIS WARRANT CERTIFICATE AND THE SHARES OF COMMON
      STOCK ISSUABLE UPON EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE
      SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”),
      OR APPLICABLE STATE SECURITIES LAWS AND NO INTEREST THEREIN MAY BE SOLD,
      TRANSFERRED OR OTHERWISE DISPOSED OF UNLESS (1) A REGISTRATION STATEMENT WITH
      RESPECT TO SUCH SECURITIES SHALL BE EFFECTIVE UNDER THE ACT AND ANY APPLICABLE
      STATE SECURITIES LAWS OR (2) SUCH SECURITIES ARE TRANSFERRED PURSUANT TO RULE
      144 PROMULGATED UNDER THE ACT (OR ANY SUCCESSOR RULE) OR (3) COMPREHENSIVE
      HEALTHCARE SOLUTIONS, INC. SHALL HAVE RECEIVED AN OPINION OF COUNSEL REASONABLY
      SATISFACTORY TO IT THAT NO VIOLATION OF THE ACT WILL BE INVOLVED IN SUCH
      TRANSFER.

     

    COMPREHENSIVE
      HEALTHCARE SOLUTIONS, INC.

     

    EXERCISABLE
      AT OR BEFORE

     

    5:00
      P.M., EASTERN TIME, AUGUST 3, 2010

     

    No.
      2                                                                                                                                                                       Warrant
      to Purchase

                                                                                                                                                                                    500,000
      Shares

     

    WARRANT
      TO PURCHASE SHARES

     

    OF
      COMMON STOCK

     

    THIS
      CERTIFIES THAT,
      for
      value received, COMPREHENSIVE
      ASSOCIATES LLC,
      a New
      York limited liability company (together with its successors and assigns, the
      “Holder”),
      with
      offices at 64 Shelter Lane, Roslyn, New York 11577, is entitled to subscribe
      for
      and purchase up to FIVE
      HUNDRED THOUSAND (500,000)
      shares,
      as adjusted pursuant to Section 4 (the “Shares”),
      of
      the fully paid and nonassessable common stock, par value $.10 per share (the
      “Common
      Stock”)
      of
COMPREHENSIVE
      HEALTHCARE SOLUTIONS, INC.,
      a
      Delaware corporation (the “Company”),
      at
      the price of FORTY
      CENTS ($0.40)
      per
      share (such price, and such other prices that shall result from time to time,
      from the adjustments specified in Section 4, the “Warrant
      Price”),
      subject to the provisions and upon the terms and conditions hereinafter set
      forth.

     

    1.  Term.
      The
      purchase right represented by this Warrant is exercisable, in whole or in part,
      at any time, and from time to time, from and after the date hereof and until
      5:00 p.m., Eastern Time, August 3, 2010. 

     

    2.  Method
      of Exercise; Payment; Issuance of New Warrant.
      

     

    (a)  The
      purchase right represented by this Warrant may be exercised by the Holder,
      in
      whole or in part and from time to time, by the surrender of this Warrant (with
      the notice of exercise form attached hereto as Annex I
      duly
      executed) at the principal office of the Company and by the payment to the
      Company of the Warrant Price in cash. 

     

     

    
      
         

      

      
         

        
          

        

      

      
         

      

    

     

    (b)  The
      persons or entities in whose name(s) any certificate(s) representing Shares
      shall be issuable upon exercise of this Warrant shall be deemed to have become
      the holder(s) of record of, and shall be treated for all purposes as the record
      holder(s) of, the Shares represented thereby (and such Shares shall be deemed
      to
      have been issued) immediately prior to the close of business on the date or
      dates upon which this Warrant is properly exercised and full payment for the
      Shares acquired pursuant to such exercise is made. Upon any exercise of the
      rights represented by this Warrant, certificates for the Shares purchased shall
      be delivered to the Holder hereof within one (1) day of receipt of such notice
      and payment, and unless this Warrant has been fully exercised or expired, a
      new
      Warrant representing the portion of Shares, if any, with respect to which this
      Warrant shall not then have been exercised shall also be issued to the holder
      hereof as soon as possible but in any event within five (5) days.

     

    3.  Stock
      Fully Paid, Reservation of Shares.
      All
      Shares that may be issued upon the exercise of this Warrant will, upon issuance,
      be duly and validly authorized and issued, fully paid and nonassessable, and
      will be free from all transfer taxes, liens and charges with respect to the
      issue thereof and assuming payment of the applicable consideration for all
      Shares so purchased, legally and validly owned by the Holder. During the period
      within which this Warrant may be exercised, the Company will at all times have
      authorized, and reserved for the sole purpose of the issue upon the exercise
      of
      the purchase rights evidenced by this Warrant, a sufficient number of shares
      of
      its Common Stock to provide for the exercise of the rights represented by this
      Warrant; and if at any time the number of authorized shares of Common Stock
      shall not be sufficient to effect the exercise of this Warrant, the Company
      will
      take such corporate action as may be necessary to increase its authorized shares
      of Common Stock to such number of shares as shall be sufficient for such
      purpose; the Company shall have analogous obligations with respect to any other
      securities or property issuable upon exercise of this Warrant. As long as this
      Warrant shall be outstanding, the Company shall use its best efforts to cause
      all shares of Common Stock issuable upon exercise of this Warrant to be listed
      and/or quoted on all securities exchanges and/or Nasdaq or other medium on
      which
      such shares may then be listed.

     

    4.  Adjustment
      of Warrant Price and Number of Shares.
      The
      number and kind of securities purchasable upon the exercise of this Warrant
      and
      the Warrant Price shall be subject to the adjustment from time to time upon
      the
      occurrence of certain events, as follows:

     

    (a)  No
      Impairment.
      The
      Company shall not, by amendment of its Certificate of Incorporation or By-laws
      or through any reorganization, recapitalization, transfer of assets,
      consolidation, merger, dissolution, issue or sale of securities or any other
      voluntary action, avoid or seek to avoid the observance or performance of any
      of
      the terms to be observed or performed hereunder by the Company, but will at
      all
      times in good faith assist in the carrying out of all the provisions of this
      Section 4 and in the taking of all such action as may be necessary or
      appropriate in order to protect the rights of the Holder against
      impairment.

     

     

    
      
         

      

      
         

        
          

        

      

      
         

      

    

     

    (b)  Below
      Exercise Price Issuance; Stock Dividends; Etc.
      

     

    	(i)  	
            Sale
              of Shares Below Warrant
              Price.

          

     

    (A)  If
      at any
      time or from time to time after the date hereof the Company issues or sells
      shares of Common Stock or Common Stock Equivalents (as hereinafter defined)
      (other than as a dividend or other distribution on any class of stock as
      provided in Section 4(b)(ii)
      below,
      or
      a subdivision or combination of shares as provided in Section 4(b)(iii)
      below)
      for an Effective
      Price (as hereinafter defined) that is less than the
      Warrant
      Price then in effect,
      then,
      and in each such case, the then existing Warrant
      Price shall be reduced, as of the opening of business on the date of
such
      issue or sale,
      to
the
      Effective Price. For purposes hereof,

     

    (I)  a
      “Common
      Stock Equivalent”
shall
      mean each share of Common Stock into which securities or property or rights
      are
      convertible, exchangeable or exercisable for or into shares of Common Stock,
      or
      otherwise entitle the holder thereof to receive directly or indirectly, any
      of
      the foregoing (provided
      that the
      Warrant Price shall be adjusted to reflect any termination of such instruments
      prior to the exercise of this Warrant); and 

     

    (II)  the
      “Effective
      Price”
of
      

     

    (x)
       a
      Common
      Stock Equivalent shall mean the sum of (x) the fair market value of the
      consideration paid for such security plus (y) the fair market value of the
      minimum consideration, if any, to be paid for the conversion, exercise or
      exchange of such security for or into each share of Common Stock, in each case
      on a per share of Common Stock basis (provided
      that the
      Warrant Price shall be adjusted to reflect adjustments to the Effective Price
      based upon any change in such minimum consideration to be paid prior to the
      exercise of this Warrant) and 

     

    (y)
       a
      share
      of Common Stock issued by the Company (other than upon the conversion, exercise
      or exchange of Common Stock Equivalents) shall be the fair market value of
      the
      consideration paid for such share of Common Stock.

     

    (B)  Consideration
      Received for Securities.
      For the
      purpose of making any adjustment required under this Section 4(b)(i),
      the
      consideration received by the Company for any issue or sale of securities shall
      (x) to
      the
      extent it consists of cash, be computed at the gross amount of cash received
      by
      the Company prior to deduction of any underwriting or similar commissions,
      compensation or concessions paid or allowed by the Company in connection with
      such
      issue or sale and
      without deduction of any expenses payable by the Company, and
      (y) to
      the
      extent it consists of property other than cash, be computed at the fair market
      value of that property as determined, in good faith, by the Board of Directors,
      and if
      additional
      shares of Common Stock and/or Common Stock Equivalents
      are
      issued or sold together with other stock or securities or other assets of the
      Company for a consideration which covers both, be computed as the portion of
      the
      consideration so received that may be reasonably determined, in good faith,
      by
      the Board of Directors to be allocable to such additional shares of Common
      Stock
and/or
      Common Stock Equivalents, which determination shall be subject to the approval
      of the
      Holder; provided
      that, in
      the event the Holder does not agree with the Company's determination of the
      value of such consideration, the 

     

     

    
      
         

      

      
         

        
          

        

      

      
         

      

       

       

      parties
        shall mutually agree upon and appoint an appraiser which shall be commissioned
        to investigate the value of the property to be distributed and shall submit
        a
        notice of an appraisal of that value to the Company and to the
        Holder within thirty (30) days of such commission. The appraiser shall be
        instructed to determine such value without regard to income tax consequences
        to
        the recipient as a result of receiving consideration other than cash. The
        value
        determined by the appraiser shall be conclusive. 

    

     

    (ii)  Adjustment
      for Common Stock Dividends and Distributions.
      If, at
      any time after the date hereof, the Company makes, or fixes a record date for
      the determination of holders of Common Stock entitled to receive, a dividend
      or
      other distribution payable in additional shares of Common Stock or Common Stock
      Equivalents, in each such event the Warrant
      Price that is then in effect shall be decreased as of the time of such issuance
      or, in the event such record date is fixed, as of the
      close
      of business on such record date,
      by
      multiplying the Warrant
      Price then in effect by a fraction (A) the
      numerator of which is the total number of shares of Common Stock and Common
      Stock Equivalents issued and outstanding immediately prior to the time of such
      issuance or the
      close
      of business on such record date,
      and
(B) the
      denominator of which is the total number of shares of Common Stock and Common
      Stock Equivalents issued and outstanding immediately prior to the time of such
      issuance or the
      close
      of business on such record date plus
      the
      number of shares of Common Stock or Common Stock Equivalents issuable in payment
      of such dividend or distribution; provided,
      however,
      that if
      such record date is fixed and such dividend is not fully paid or if such
      distribution is not fully made on the date fixed therefor, the Warrant
      Price shall be recomputed accordingly as of the
      close
      of business on such record date and
      thereafter the Warrant
      Price shall be adjusted pursuant to this Section 4(b)(ii) to reflect the
      actual payment of such dividend or distribution.

     

    (iii)  Adjustments
      for Stock Splits, Stock Subdivisions and Combinations.
      If, at
      any time after the date hereof, the Company subdivides or combines the Common
      Stock, (A) in
      the
      case of a subdivision (including a stock split), the Warrant
      Price in effect immediately
      prior to such event
      shall be proportionately decreased and the number of shares of Common Stock
      purchasable hereunder shall be proportionately increased, and (B) in
      the
      case of a combination (including a reverse stock split), the Warrant
      Price in effect immediately
      prior to such event
      shall be proportionately increased and the number of shares of Common Stock
      purchasable hereunder shall be proportionately decreased. Any adjustment under
      this Section 4(b)(iii)
      shall
      become effective at the
      close
      of business on the date the
      subdivision or combination becomes effective.

     

    (iv)  Adjustments
      for Reclassification, Reorganization, Merger, Consolidation and
      Sale.
      In case
      of (A) any
      reclassification, reorganization, change or conversion of securities of the
      Common Stock (other than a change in par value, or from par value to no par
      value) into other shares or securities of the Company, or (B) any
      merger or consolidation of the Company with or into another entity (other than
      a
      merger or consolidation with another entity in which the Company is the
      acquiring and the surviving entity and that does not result in any
      reclassification or change of the Common Stock),
      or
(C) any
      sale
      of all or substantially all the assets of the Company, the 

     

     

    
      
         

      

      
         

        
          

        

      

      
         

      

       

       

      Holder
        shall
        have the right to receive, in lieu of the shares of Common Stock for
        which
        this Warrant is exercisable, the kind and amount of shares of stock and other
        securities, money and property receivable upon such reclassification,
        reorganization, change, merger or consolidation upon exercise by the Holder
        of
        the maximum number of shares of Common Stock for which this Warrant could
        have been exercised immediately
        prior to such reclassification,
        reorganization, change, merger, consolidation or sale, all subject to further
        adjustment as provided herein or with respect to such other securities or
        property by the terms thereof. The provisions of this clause (iv)
        shall
        similarly attach to successive reclassifications, reorganizations, changes,
        mergers, consolidations or sales.

    

     

    (c)  Other
      Distributions.
      In the
      event the Company provides the holders of its Common Stock with consideration
      that is not otherwise addressed in this Section 4 (including, without
      limitation, declaring a distribution payable in securities, assets, cash or
      evidences of indebtedness issued by other persons or the Company (excluding
      cash
      dividends declared and paid by the Company out of retained earnings), then,
      in
      each such case, the Holder shall be entitled to a pro rata
      share of
      any such distribution as though the Holder was a holder of the number of shares
      of Common Stock of the Company issuable upon the exercise of this Warrant in
      whole as of the record date fixed for the determination of the holders of Common
      Stock of the Company entitled to receive such distribution.

     

    (d)  Recapitalizations.
      If at
      any time there occurs a recapitalization of the Common Stock (other than a
      subdivision, combination, merger, consolidation or sale of assets provided
      for
      in this Section 4), the Holder shall be entitled to receive upon exercise
      of this Warrant the number of shares of capital stock or other securities or
      property of the Company or otherwise, to which a holder of the Common Stock
      deliverable upon exercise would have been entitled on such recapitalization.
      In
      any such case, appropriate adjustment shall be made in the application of the
      provisions of this Section 4 with respect to the rights of the Holder after
      the
      recapitalization to the end that the provisions of this Section 4 (including
      adjustment of the Warrant Price then in effect and the number of shares
      purchasable upon exercise of this Warrant) shall be applicable after that event
      as nearly equivalent as may be practicable.

     

    (e)  Notice
      of Adjustments.
      Whenever there shall be any change pursuant to this Section 4, the Company
      shall
      prepare a certificate setting forth, in reasonable detail, the event requiring
      the change and the kind and amount of shares of stock and other securities,
      money and property subsequently issuable upon an exercise hereof. Such
      certificate shall be signed by its chief financial officer and shall be
      delivered to the Holder or such other person as the Holder or any successor
      notice recipient may designate.

     

    (f)  Fractional
      Shares; Rounding.
      No
      fractional shares of Common Stock will be issued in connection with any exercise
      hereunder, but in lieu of such fractional shares, the number of shares of Common
      Stock to be received by the Holder upon exercise shall be
      rounded up to the nearest whole share.
      All
      calculations under this Section 4 shall be made to the nearest cent or to
      the nearest one-hundredth of a share, as the case may be.

     

    

    
      
         

      

      
         

        
          

        

      

      
         

      

    

     

    5.  Compliance
      with Securities Act; Disposition of Warrant or Shares of Common
      Stock.
      

     

    (a) The
      Holder, by acceptance hereof, agrees that this Warrant and the Shares to be
      issued upon the exercise hereof are being acquired for investment and that
      such
      holder will not offer, sell or otherwise dispose of this Warrant or any Shares
      to be issued upon the exercise hereof except under circumstances which will
      not
      result in a violation of applicable securities laws. All Shares issued upon
      exercise of this Warrant (unless registered under the Act) shall be stamped
      or
      imprinted with a legend in substantially the following form:

     

    “THE
      SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE
      SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”),
      OR APPLICABLE STATE SECURITIES LAWS AND NO INTEREST THEREIN MAY BE SOLD,
      TRANSFERRED OR OTHERWISE DISPOSED OF UNLESS (1) A REGISTRATION STATEMENT WITH
      RESPECT TO SUCH SECURITIES SHALL BE EFFECTIVE UNDER THE ACT AND ANY APPLICABLE
      STATE SECURITIES LAWS OR (2) SUCH SECURITIES ARE TRANSFERRED PURSUANT TO RULE
      144 PROMULGATED UNDER THE ACT (OR ANY SUCCESSOR RULE) OR (3) COMPREHENSIVE
      HEALTHCARE SOLUTIONS, INC. SHALL HAVE RECEIVED AN OPINION OF COUNSEL REASONABLY
      SATISFACTORY TO IT THAT NO VIOLATION OF THE ACT WILL BE INVOLVED IN SUCH
      TRANSFER.”

     

    (b)  Subject
      to the Company’s prior approval, which will not be unreasonably withheld,
      delayed or conditioned, this Warrant may be transferred or assigned, in whole
      or
      in part, by the Holder. Notwithstanding the foregoing, this Warrant may be
      transferred or assigned, in whole or in part, by the Holder to its members
      without the prior approval of the Company. This Warrant and all of the
      provisions hereof shall be binding upon and inure to the benefit of the Company,
      the Holder and their respective successors and assigns.

     

    (c)  Pursuant
      to a Registration Rights Agreement of even date between the Company and the
      Holder, the Holder has been granted certain registration rights with respect
      to
      the resale of the Shares issuable upon the exercise thereof.

     

    6.  Rights
      as a Shareholder.
      The
      Holder, as such, shall not be entitled to vote or receive dividends or be deemed
      the holder of Shares or any other securities of the Company which may at any
      time be issuable on the exercise hereof, nor shall anything contained herein
      be
      construed to confer upon the Holder, as such, any right to vote as a shareholder
      for the election of directors or upon any matter submitted to shareholders
      at
      any meeting thereof, or to receive notice of meetings, or to receive dividends
      or subscription rights or otherwise until this Warrant is exercised and the
      Shares purchasable upon the exercise hereof shall have become deliverable,
      as
      provided herein.

     

     

    
      
         

      

      
         

        
          

        

      

      
         

      

    

     

    7.  Representations
      and Warranties.
      The
      Company represents and warrants to the Holder as follows:

     

    (a) The
      Company has all requisite corporate power and authority to authorize and execute
      this Warrant and the certificates evidencing the Shares and to perform all
      obligations and undertakings under this Warrant; 

     

    (b)
       This
      Warrant has been duly authorized and executed by the Company and is a valid
      and
      binding obligation of the Company enforceable in accordance with its
      terms;

     

    (c) The
      Shares have been duly authorized and reserved for issuance by the Company and,
      when issued in accordance with the terms hereof, will be validly issued, fully
      paid and nonassessable; and

     

    (d)  Neither
      the execution and delivery of this Warrant, nor the issuance of the Shares
      upon
      exercise of this Warrant in accordance with the terms hereof, will be
      inconsistent with the Company’s Certificate of Incorporation or By-laws, as
      amended, and do not and will not constitute a default under any indenture,
      mortgage, contract, other instrument, judgment, decree or order to which the
      Company is a party or by which it is bound.

     

    8.  Miscellaneous.
      (a)  This Warrant represents the entire agreement between the parties
      hereto with respect to the subject matter thereof. This Warrant may not be
      modified or amended, or any provisions hereof waived, except by written
      agreement of the Company and the Holder.

     

    (b)  All
      notices, demands and requests of any kind to be delivered to any party in
      connection with this Warrant shall be in writing and shall be deemed to have
      been duly given if personally or hand delivered or if sent by a recognized
      overnight delivery courier or by registered or certified mail, return receipt
      requested and postage prepaid, or by facsimile transmission addressed as
      follows:

     

           (i)  if
      to the
      Company, to:

     

    Comprehensive
      Healthcare Solutions, Inc.

    45
      Ludlow
      Street, Suite 602

    Yonkers,
      New York 10705

    Attention:
      John H. Treglia, Chairman of the Board & Chief Executive
      Officer

    Facsimile:
      (914) 375-3696

     

     

    
      
         

      

      
         

        
          

        

      

      
         

      

    

    
 

    with
      a
      copy to:

    

    Anslow
      & Jaclin, LLP

    195
      Route
      9, Suite 204

    Manalapan,
      New Jersey 07726

    Attention:
      Gregg E. Jaclin, Esq.

    Facsimile:
      (732) 577-1188

     

    (ii)  if
      to the
      Holder, to:

     

    Comprehensive
      Associates LLC

    64
      Shelter Lane

    Roslyn,
      New York 11577

    Attention:
      Robyn Schreiber

    Facsimile:
      (516) 621-9172

    

    with
      a
      copy to:

    

    Certilman
      Balin Adler & Hyman, LLP

    90
      Merrick Avenue, 9th Floor

    East
      Meadow, New York 11554

    Attention:
      Fred Skolnik, Esq.

    Facsimile:
      (516) 296-7111

    

    or
      to
      such other address as the party to whom notice is to be given may have furnished
      to the other party hereto in writing in accordance with provisions of this
      Section 7. Any such notice or communication shall be deemed to have been
      effectively given (i) in the case of personal or hand delivery, on the date
      of such delivery, (ii) in the case of a recognized overnight delivery
      courier, on the business day after the date when sent, (iii) in the case of
      mailing, on the third business day following that day on which the piece of
      mail
      containing such communication is posted and (iv) in the case of facsimile
      transmission, on the date of transmission. 

     

    (c)  The
      Company covenants to the Holder that upon receipt of a description of
      circumstances reasonably satisfactory to the Company of the loss, theft,
      destruction or mutilation of this Warrant and, in the case of any such loss,
      theft or destruction, upon receipt of an indemnity reasonably satisfactory
      to
      the Company, or in the case of any such mutilation upon surrender and
      cancellation of such Warrant, the Company will make and deliver a new Warrant,
      of like tenor, in lieu of the lost, stolen, destroyed or mutilated
      Warrant.

    

    (d)  The
      descriptive headings of the several sections and paragraphs contained in this
      Warrant are for reference purposes only and shall not affect in anyway the
      meaning or interpretation of this Warrant.

     

     

    
      
         

      

      
         

        
          

        

      

      
         

      

    

    
 

    (e)  This
      Warrant shall be governed by and construed in accordance with the internal
      laws
      of the State of New York, without giving effect to the principles of conflicts
      of laws. 

    

    (f)  The
      invalidity of any of the provisions of this Warrant shall not invalidate or
      otherwise affect any of the other provisions of this Warrant, which shall remain
      in full force and effect.

    

    (g)  The
      Company acknowledges that it has been represented by counsel in connection
      with
      this Warrant. Accordingly, any rule or law or any legal decision that would
      require the interpretation of any claimed ambiguities in this Warrant against
      the party that drafted it has no application and is expressly waived by the
      Company. The provisions of this Warrant shall be interpreted in a reasonable
      manner to give effect to the intent of the parties hereto.

    

    

    {Remainder
      of page intentionally left blank. Signature page
      follows.}

    

     

    
      
        
          

        

         

      

      
         

        
          

        

      

      
         

        
          

        

      

    

    IN
      WITNESS WHEREOF,
      the
      Company has caused this Warrant to be duly executed by a duly authorized officer
      as of the 3rd
      day of
      August, 2005.

     

    COMPREHENSIVE
      HEALTHCARE SOLUTIONS, INC.

    

    

    By:
      ______________________________

    John
      Treglia, 

    Chairman
      of the Board & Chief Executive Officer 

    

     

    

     

    
      
         

      

      
         

        
          

        

      

      
         

      

    

    

    

     

    FORM
      OF EXERCISE NOTICE

     

    To:     Comprehensive
      Healthcare Solutions, Inc.

            45
      Ludlow
      Street, Suite 602

    Yonkers,
      New York 10705

    Attention:
      John Treglia

    Facsimile:
      (914) 375-3696

    

     

    1.  The
      undersigned hereby elects to purchase __________ shares of Common Stock of
      Comprehensive Healthcare Solutions, Inc. pursuant to the terms of the attached
      Warrant, and tenders herewith full payment of the purchase price of such shares
      in cash. 

     

    2.  Please
      issue a certificate or certificates representing said shares in the name of
      the
      undersigned or in such other name or names as are specified below:

     

    (Name)

     

    (Address)

     

    3.  The
      undersigned represents that the aforesaid shares are being acquired for the
      account of the undersigned for investment and not with a view to, or for resale
      in connection with, the distribution thereof and that the undersigned has no
      present intention of distributing or reselling such shares in a manner that
      would cause the issuance of the underlying shares to be in violation of
      applicable securities laws.

     

     

     

    

     

    By:      

     

    

     

    Address:     

     

     

     

    

     

    Taxpayer
      Identification No.:   

     

    

     

    Date:
      _______________________________

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00113-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00113-of-00352.parquet"}]]